Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants

Clinical trial NCT07230834 · RECRUITING

Trial details

NCT number: NCT07230834
Sponsor: Regeneron Pharmaceuticals
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Geographic Atrophy (GA)

Start date: 2026-01-19
Primary completion: 2028-07-03
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.